Literature DB >> 23408588

Do γδ T cells predict osteonecrosis of the jaw?

M Neale Weitzmann1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23408588      PMCID： PMC4316197          DOI： 10.1002/jbmr.1886

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN： 0884-0431            Impact factor:   6.741


× No keyword cloud information.
  48 in total

1.  Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha.

Authors:  S Cenci; M N Weitzmann; C Roggia; N Namba; D Novack; J Woodring; R Pacifici
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

Review 2.  HIV and bone metabolism.

Authors:  Ighovwerha Ofotokun; M Neale Weitzmann
Journal:  Discov Med       Date:  2011-05       Impact factor: 2.970

3.  Activated T lymphocytes support osteoclast formation in vitro.

Authors:  N J Horwood; V Kartsogiannis; J M Quinn; E Romas; T J Martin; M T Gillespie
Journal:  Biochem Biophys Res Commun       Date:  1999-11       Impact factor: 3.575

4.  T cell activation induces human osteoclast formation via receptor activator of nuclear factor kappaB ligand-dependent and -independent mechanisms.

Authors:  M N Weitzmann; S Cenci; L Rifas; J Haug; J Dipersio; R Pacifici
Journal:  J Bone Miner Res       Date:  2001-02       Impact factor: 6.741

5.  Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.

Authors:  Y Y Kong; U Feige; I Sarosi; B Bolon; A Tafuri; S Morony; C Capparelli; J Li; R Elliott; S McCabe; T Wong; G Campagnuolo; E Moran; E R Bogoch; G Van; L T Nguyen; P S Ohashi; D L Lacey; E Fish; W J Boyle; J M Penninger
Journal:  Nature       Date:  1999-11-18       Impact factor: 49.962

6.  Can peripheral blood γδ T cells predict osteonecrosis of the jaw? An immunological perspective on the adverse drug effects of aminobisphosphonate therapy.

Authors:  Shirin Kalyan; Elgar Susanne Quabius; Jörg Wiltfang; Heiner Mönig; Dieter Kabelitz
Journal:  J Bone Miner Res       Date:  2013-04       Impact factor: 6.741

7.  T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma.

Authors:  H Takayanagi; K Ogasawara; S Hida; T Chiba; S Murata; K Sato; A Takaoka; T Yokochi; H Oda; K Tanaka; K Nakamura; T Taniguchi
Journal:  Nature       Date:  2000-11-30       Impact factor: 49.962

Review 8.  HIV-1 infection and antiretroviral therapies: risk factors for osteoporosis and bone fracture.

Authors:  Ighovwerha Ofotokun; M Neale Weitzmann
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-12       Impact factor: 3.243

9.  TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand.

Authors:  J Lam; S Takeshita; J E Barker; O Kanagawa; F P Ross; S L Teitelbaum
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

10.  Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways.

Authors:  Y H Zhang; A Heulsmann; M M Tondravi; A Mukherjee; Y Abu-Amer
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157
View more
  2 in total

Review 1.  T-cells and B-cells in osteoporosis.

Authors:  M Neale Weitzmann
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-12       Impact factor: 3.243

Review 2.  The Interplay between the bone and the immune system.

Authors:  Giorgio Mori; Patrizia D'Amelio; Roberta Faccio; Giacomina Brunetti
Journal:  Clin Dev Immunol       Date:  2013-07-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.